Hemang Resources Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Hemang Resources Ltd is ₹ 7.56 as of 23 Oct 15:30 . The P/E Ratio of Hemang Resources Ltd changed from 1.8 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Hemang Resources Ltd changed from ₹ 7.97 crore on March 2021 to ₹ 11.95 crore on March 2026 . This represents a CAGR of 6.98% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Hemang Resources Ltd for the Jun '26 is ₹ 0.01 crore as compare to the Mar '26 revenue of ₹ 6.84 crore. This represent the decline of -99.85% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Hemang Resources Ltd for the Jun '26 is ₹ -0.17 crore as compare to the Mar '26 ebitda of ₹ -0.67 crore. This represent the decline of -74.63% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Hemang Resources Ltd changed from ₹ -0.2 crore to ₹ -0.17 crore over 9 quarters. This represents a CAGR of -6.97% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Hemang Resources Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Hemang Resources Ltd

Hemang Resources Limited was initially established as BCC Housing Finance and Leasing Company Limited as a Non Banking Financial Institution.
The Company was initially engaged in finance of leasing and hire purchase business.
In 1994, the name of the Company was changed to BCC Finance Limited and in 2006, it changed to Bhatia Industries & Infrastructure Limited and further was changed to Hemang Resources Limited in 2015. The Company had opted to exit from the business of a non-banking financial institution and therefore the Reserve Bank of India had in year 2006 cancelled the Certificate of Registration granted to M/s BCC Finance Limited, Indore for carrying on the business of a Non-Banking Financial Institution.
Following cancellation of Registration Certificate, M/s BCC Finance Limited, cannot transact the business of a non-banking financial institution.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Hemang Resources Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Hemang Resources Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Hemang Resources Ltd is 9 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Hemang Resources Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Hemang Resources Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hemang Resources Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Hemang Resources Ltd stock price is INR ₹7.56. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Hemang Resources Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Hemang Resources Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.